The Food and Drug Administration’s approval of the abortion drug RU-486 sparked a new round of debate between pro-life and pro-choice activists, but it also brought forth a new discussion about the drug’s medical benefits and drawbacks, who will be allowed to administer it, and how states will regulate its use. A panel talks about the new concerns raised by the introduction of RU-486 in the U.S.


  • Richard Pierce professor of administrative law at George Washington University
  • Dr. Mitchell Creinin physician
  • Maxine Klane Planned Parenthood of Metropolitan Washington

Related Links

Topics + Tags


comments powered by Disqus
Most Recent Shows

Ben Bernanke: “The Courage to Act”

Tuesday, Oct 06 2015Ben Bernanke was chair of the Federal Reserve during what became the worst financial crisis since the Great Depression. An inside look at the meltdown from the former Fed chair and his defense of bailing out Wall Street.